Amicogen Inc is a company based in South Korea.
| Website | http://www.amicogen.com/ |
| Revenue | $83.2 million |
| Employees | 25 (14 on RocketReach) |
| Founded | 2000 |
| Address | 64 Dongburo 1259, Chinju, Gyeongsangnam 52621, KR |
| Phone | +82 55-759-6161 |
| Fax | +82 55-759-6094 |
| Technologies |
JavaScript
,
HTML
,
PHP
+3 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services |
| Web Rank | 9 Million |
| Keywords | Biotechnology, Drug Development, Pharmaceutical, Therapeutics, Cell Line Development, Biologics, Clinical Trials, Protein Engineering, Bioprocessing, Immunology, Research, Development, Manufacturing, Cancer Treatment, Oncology, Healthcare, Treatment, Innovation |
| Competitors | BASF, DuPont, DSM, Evonik, Novozymes, Codexis, Inc., Geno, Probi AB, Aventis +29 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Amicogen, Inc. employee's phone or email?
The Amicogen, Inc. annual revenue was $83.2 million in 2026.
Myung-Jeom Ryu is the Chief Technology Officer and Head of R and D center of Enzyme and Biopharmaceutical unit of Amicogen, Inc..
14 people are employed at Amicogen, Inc..
Amicogen, Inc. is based in Chinju, Gyeongsangnam.
The NAICS codes for Amicogen, Inc. are [5417, 541713, 54171, 54, 541].
The SIC codes for Amicogen, Inc. are [87, 873].